Dr. Lizza Lebron-Zapata, MD

Dr. Lebron-Zapata practices at Columbia Memorial Health in Hudson, New York, part of Albany Med Health System.

Dr. Lebron-Zapata's NPI, 1740445204, was assigned on July 24, 2008. Dr. Lebron-Zapata graduated from Autonomous University of Barcelona Faculty of Medicine in 2005. Dr. Lebron-Zapata holds New York license 264382.

Dr. Lebron-Zapata's primary practice is Columbia Memorial Health, at 71 Prospect Avenue, Hudson, NY 12534 in Columbia County. The practice phone is (518) 828-7601.

Dr. Lebron-Zapata's primary practice is Columbia Memorial Health in Hudson, New York, part of Albany Med Health System. Dr. Lebron-Zapata is also affiliated with Memorial Sloan Kettering Cancer Center. The medical group on file is SimonMed Imaging. Dmand AI also links Dr. Lebron-Zapata to 12 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lebron-Zapata practices, 3 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Lebron-Zapata's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Lebron-Zapata is board certified in nuclear medicine by the American Board of Nuclear Medicine. Dmand AI has Dr. Lebron-Zapata's licenses on file in 7 states: New York, New Jersey, Arizona, California, Florida, North Carolina and Pennsylvania.

CMS data shows 1,372 Medicare services from Dr. Lebron-Zapata across 8 procedure codes in 2024, for 1,368 Medicare patients. Medicare paid $114,018 for them. Every service was in an office.

CMS counts 1,368 Medicare patients who saw Dr. Lebron-Zapata in 2024. The largest group is 65 to 74, with 596 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lebron-Zapata's median patient age at 67, with 47% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Lebron-Zapata for performance year 2024, reported as part of a group. Dr. Lebron-Zapata accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Lebron-Zapata, published from 2017 to 2019. 2019 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Contrast Media and Early Detection of Cancer. Dr. Lebron-Zapata's most frequent co-authors are Christopher Andrew Barker, MD, Sandra B. Brennan, MBCHB and Mary L. Gemignani, MD.

CMS Open Payments shows 1 general payment to Dr. Lebron-Zapata from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. La Jolla Pharmaceutical Company paid the most, $13.

Dr. Lebron-Zapata graduated from Autonomous University of Barcelona Faculty of Medicine in 2005.

Dr. Lebron-Zapata is in network with 18 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.